S. Korea Doctors Cleared To Bypass H1N1 Tests Before Giving Tamiflu
This article was originally published in PharmAsia News
Executive Summary
South Korea's CDC has cleared the nation's physicians to provide Roche's Tamiflu (oseltamivir) without having to conduct infection tests for the H1N1 flu virus. The KCDC also said that despite concerns about the antiviral's side effects, it would provide a list of hospitals and pharmacies where the public can obtain the drug. The KCDC's director said it was aware of the risk and that there is some resistance to Tamiflu, but the agency decided the need to slow the spread of the virus was more important. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.